NCT03896633View on ClinicalTrials.gov

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

637

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

November 17, 2018

Study Completion Date

November 17, 2018

Conditions
GlaucomaOpen Angle or Ocular Hypertension
Interventions
DRUG

brinzolamide 1% ophthalmic suspension

brinzolamide 1% ophthalmic suspension

DRUG

Azopt 1%

Azopt 1%, RLD

Trial Locations (1)

08807

Various, Bridgewater

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT03896633 - Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt | Biotech Hunter | Biotech Hunter